Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.
Altay Therapeutics has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in September 2022.
Altay Therapeutics's investors include Y Combinator, Creative Destruction Lab, Bossa Invest, Tachyon Ventures, FSHD Global.
Altay Therapeutics is headquartered in San Francisco, United States.
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.
Altay Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Altay Therapeutics — Funding & Investors." VCBacked, September 21, 2022, https://www.vcbacked.co/company/altay-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). Altay Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/altay-therapeutics
{{cite web |title=Altay Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/altay-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated